2 assets in Neuritis
Therapeutic assets addressing Neuritis, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Dolutegravir Neuritis | Carlos Brites | P2 | CCC (53) |
Tenofovir Neuritis | Carlos Brites | P2 | CCC (53) |
Therapeutic assets addressing Neuritis, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Dolutegravir Neuritis | Carlos Brites | P2 | CCC (53) |
Tenofovir Neuritis | Carlos Brites | P2 | CCC (53) |